Get startedLog in
    Picture of Bioera SpA logo

    BIE — Bioera SpA Cashflow Statement

    0.000.00%
    it flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Bioera SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    R2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-7.92-6.3615.3-5.19-3.84
    Depreciation
    Amortisation
    Non-Cash Items3.131.26-17.94.372.15
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital4.991.770.1354.320.249
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities1.24-2.64-2.253.79-1.2
    Capital Expenditures-0.016—-0.064—-0.312
    Purchase of Fixed Assets
    Other Investing Cash Flow Items0.1770.3290.2631.26—
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Sale of Intangible Assets
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities0.1610.3290.1991.26-0.312
    Financing Cash Flow Items0.687-1.551.340.8290.537
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1.742.261.94-5.211.71
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-0.339-0.05-0.113-0.1610.201